Paper8916751
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.
Walker MC and 2 others. BMJ, 1996. Cited by 34 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome. Papers, record 8916751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8916751
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epilepsy | Major topic |
| Triazines | Major topic |
| gamma-Aminobutyric Acid | Major topic |
| Chronic Disease | |
| Clinical Trials as Topic | |
| Follow-Up Studies | |
| Humans | |
| Lamotrigine | |
| Survival Rate | |
| Treatment Outcome | |
| Vigabatrin |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 8,916,729 | Drug trials in epilepsy. | https://conductscience.org/library/papers/8916729 | PubMed |
| Comment in | 8,963,199 | Newly licensed drugs. | https://conductscience.org/library/papers/8963199 | PubMed |
References3
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8,437,003 | Mortality in patients with epilepsy: a study of patients in long term residential care. | J Neurol Neurosurg Psychiatry | 1993 | https://conductscience.org/library/papers/8437003 | PubMed |
| 2 | 7,738,555 | Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. | J Neurol Neurosurg Psychiatry | 1995 | https://conductscience.org/library/papers/7738555 | PubMed |
| 3 | 2,289,481 | The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy. | Epilepsy Res | 1990 | https://conductscience.org/library/papers/2289481 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 14,685,800 | Dropout rates with olanzapine or risperidone: a multi-centre observational study. | Eur J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14685800 | PubMed |
| 11,851,635 | The promise of new antiepileptic drugs. | Br J Clin Pharmacol | 2002 | https://conductscience.org/library/papers/11851635 | PubMed |
| 10,329,750 | Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic. | J Neurol Neurosurg Psychiatry | 1999 | https://conductscience.org/library/papers/10329750 | PubMed |
| 10,186,463 | The need for pharmacoeconomic evaluations in the NHS. | Pharmacoeconomics | 1998 | https://conductscience.org/library/papers/10186463 | PubMed |
| 8,963,199 | Newly licensed drugs. | BMJ | 1996 | https://conductscience.org/library/papers/8963199 | PubMed |
| 8,916,729 | Drug trials in epilepsy. | BMJ | 1996 | https://conductscience.org/library/papers/8916729 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8916751
GET https://conductscience.org/api/papers/v1/8916751/authors